FDA says Pfizer Covid vaccine benefits outweigh risks for kids ages 5 to 11

Agency reviewers stopped short of calling for Pfizer’s shot to be authorized. The agency will put that question to a panel of independent advisers Oct. 26.

FDA says Pfizer Covid vaccine benefits outweigh risks for kids ages 5 to 11
Agency reviewers stopped short of calling for Pfizer’s shot to be authorized. The agency will put that question to a panel of independent advisers Oct. 26.